Literature DB >> 17207415

Expanding the scope of crystal form evaluation in pharmaceutical science.

Matthew L Peterson1, Magali B Hickey, Michael J Zaworotko, Orn Almarsson.   

Abstract

The commentary seeks to provide a brief history and perspective on the importance of crystal forms of pharmaceuticals as a means of achieving performance criteria. The expanding scope of crystal form selection, emergence of crystal engineering in pharmaceutical science and pharmaceutical co-crystals are topics of this brief review.

Mesh:

Substances:

Year:  2006        PMID: 17207415

Source DB:  PubMed          Journal:  J Pharm Pharm Sci        ISSN: 1482-1826            Impact factor:   2.327


  8 in total

1.  Crystalline vs. ionic liquid salt forms of active pharmaceutical ingredients: a position paper.

Authors:  Jelena Stoimenovski; Douglas R MacFarlane; Katharina Bica; Robin D Rogers
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

2.  Co-crystals: a novel approach to modify physicochemical properties of active pharmaceutical ingredients.

Authors:  A V Yadav; A S Shete; A P Dabke; P V Kulkarni; S S Sakhare
Journal:  Indian J Pharm Sci       Date:  2009-07       Impact factor: 0.975

3.  Cyanoximes as effective and selective co-crystallizing agents.

Authors:  Christer B Aakeröy; Debra J Salmon; Michelle M Smith; John Desper
Journal:  CrystEngComm       Date:  2009-01-01       Impact factor: 3.545

4.  Revealing Polymorphic Phase Transformations in Polymer-Based Hot Melt Extrusion Processes.

Authors:  José R Hernández Espinell; Vilmalí López-Mejías; Torsten Stelzer
Journal:  Cryst Growth Des       Date:  2018-03-09       Impact factor: 4.076

5.  Impact of crystal polymorphism on the systemic bioavailability of rifaximin, an antibiotic acting locally in the gastrointestinal tract, in healthy volunteers.

Authors:  Corrado Blandizzi; Giuseppe Claudio Viscomi; Carmelo Scarpignato
Journal:  Drug Des Devel Ther       Date:  2014-12-16       Impact factor: 4.162

6.  Polymorphic Characterization, Pharmacokinetics, and Anti-Inflammatory Activity of Ginsenoside Compound K Polymorphs.

Authors:  Yun-Yan Kuang; Xuan Gao; Yi-Jun Niu; Xun-Long Shi; Wei Zhou
Journal:  Molecules       Date:  2021-04-01       Impact factor: 4.411

7.  2-(1,3-Dioxoisoindolin-2-yl)acetic acid-N'-[(E)-2-meth-oxy-benzyl-idene]pyridine-4-carbohydrazide (1/1).

Authors:  Shaaban K Mohamed; Muhammad Akhyar Farrukh; Mehmet Akkurt; Mustafa R Albayati; Antar A Abdelhamid
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-07-14

Review 8.  Ionic Liquids Toxicity-Benefits and Threats.

Authors:  Jolanta Flieger; Michał Flieger
Journal:  Int J Mol Sci       Date:  2020-08-29       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.